位置:首页 > 蛋白库 > MYPOP_HUMAN
MYPOP_HUMAN
ID   MYPOP_HUMAN             Reviewed;         399 AA.
AC   Q86VE0;
DT   22-JUL-2008, integrated into UniProtKB/Swiss-Prot.
DT   26-APR-2005, sequence version 2.
DT   03-AUG-2022, entry version 144.
DE   RecName: Full=Myb-related transcription factor, partner of profilin;
DE   AltName: Full=Myb-related protein p42POP;
DE   AltName: Full=Partner of profilin;
GN   Name=MYPOP; Synonyms=P42POP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Transcriptional repressor; DNA-binding protein that
CC       specifically recognizes the core sequence 5'-YAAC[GT]G-3'. Dimerization
CC       with PFN1 reduces its DNA-binding capacity (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with PFN1. Homodimer and heterodimer with PFN1 (By
CC       similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q86VE0; Q9ULX6: AKAP8L; NbExp=3; IntAct=EBI-2858213, EBI-357530;
CC       Q86VE0; O95429: BAG4; NbExp=3; IntAct=EBI-2858213, EBI-2949658;
CC       Q86VE0; Q96PG8: BBC3; NbExp=3; IntAct=EBI-2858213, EBI-17289784;
CC       Q86VE0; Q9BWT7: CARD10; NbExp=3; IntAct=EBI-2858213, EBI-3866279;
CC       Q86VE0; Q9UKJ5: CHIC2; NbExp=3; IntAct=EBI-2858213, EBI-741528;
CC       Q86VE0; A0PJX0: CIB4; NbExp=3; IntAct=EBI-2858213, EBI-12868028;
CC       Q86VE0; A8MQ03: CYSRT1; NbExp=3; IntAct=EBI-2858213, EBI-3867333;
CC       Q86VE0; Q13643: FHL3; NbExp=3; IntAct=EBI-2858213, EBI-741101;
CC       Q86VE0; P31943: HNRNPH1; NbExp=3; IntAct=EBI-2858213, EBI-351590;
CC       Q86VE0; P61978-2: HNRNPK; NbExp=3; IntAct=EBI-2858213, EBI-7060731;
CC       Q86VE0; P49639: HOXA1; NbExp=3; IntAct=EBI-2858213, EBI-740785;
CC       Q86VE0; O75525: KHDRBS3; NbExp=3; IntAct=EBI-2858213, EBI-722504;
CC       Q86VE0; Q92845: KIFAP3; NbExp=3; IntAct=EBI-2858213, EBI-954040;
CC       Q86VE0; Q6A162: KRT40; NbExp=3; IntAct=EBI-2858213, EBI-10171697;
CC       Q86VE0; Q8IUG1: KRTAP1-3; NbExp=3; IntAct=EBI-2858213, EBI-11749135;
CC       Q86VE0; P60409: KRTAP10-7; NbExp=3; IntAct=EBI-2858213, EBI-10172290;
CC       Q86VE0; P60410: KRTAP10-8; NbExp=3; IntAct=EBI-2858213, EBI-10171774;
CC       Q86VE0; P60411: KRTAP10-9; NbExp=3; IntAct=EBI-2858213, EBI-10172052;
CC       Q86VE0; P59991: KRTAP12-2; NbExp=3; IntAct=EBI-2858213, EBI-10176379;
CC       Q86VE0; Q3LI72: KRTAP19-5; NbExp=3; IntAct=EBI-2858213, EBI-1048945;
CC       Q86VE0; Q3LI70: KRTAP19-6; NbExp=3; IntAct=EBI-2858213, EBI-12805508;
CC       Q86VE0; Q9BYR8: KRTAP3-1; NbExp=3; IntAct=EBI-2858213, EBI-9996449;
CC       Q86VE0; Q6L8G9: KRTAP5-6; NbExp=3; IntAct=EBI-2858213, EBI-10250562;
CC       Q86VE0; Q99750: MDFI; NbExp=3; IntAct=EBI-2858213, EBI-724076;
CC       Q86VE0; Q5JR59-3: MTUS2; NbExp=5; IntAct=EBI-2858213, EBI-11522433;
CC       Q86VE0; O43639: NCK2; NbExp=3; IntAct=EBI-2858213, EBI-713635;
CC       Q86VE0; Q7Z6G3-2: NECAB2; NbExp=3; IntAct=EBI-2858213, EBI-10172876;
CC       Q86VE0; P0DPK4: NOTCH2NLC; NbExp=3; IntAct=EBI-2858213, EBI-22310682;
CC       Q86VE0; Q9GZV8: PRDM14; NbExp=3; IntAct=EBI-2858213, EBI-3957793;
CC       Q86VE0; P79522: PRR3; NbExp=3; IntAct=EBI-2858213, EBI-2803328;
CC       Q86VE0; P98179: RBM3; NbExp=3; IntAct=EBI-2858213, EBI-2949699;
CC       Q86VE0; P38159: RBMX; NbExp=3; IntAct=EBI-2858213, EBI-743526;
CC       Q86VE0; P0DJD3-2: RBMY1A1; NbExp=3; IntAct=EBI-2858213, EBI-11994018;
CC       Q86VE0; Q6ZRY4: RBPMS2; NbExp=3; IntAct=EBI-2858213, EBI-11987469;
CC       Q86VE0; P21673: SAT1; NbExp=3; IntAct=EBI-2858213, EBI-711613;
CC       Q86VE0; O60506-4: SYNCRIP; NbExp=3; IntAct=EBI-2858213, EBI-11123832;
CC       Q86VE0; P22735: TGM1; NbExp=3; IntAct=EBI-2858213, EBI-2562368;
CC       Q86VE0; Q63HR2: TNS2; NbExp=3; IntAct=EBI-2858213, EBI-949753;
CC       Q86VE0; P62995: TRA2B; NbExp=3; IntAct=EBI-2858213, EBI-725485;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC   -!- DOMAIN: The proline-rich region is required for PFN1 interaction.
CC       {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC044311; AAH44311.2; -; mRNA.
DR   CCDS; CCDS33055.1; -.
DR   RefSeq; NP_001012661.1; NM_001012643.3.
DR   AlphaFoldDB; Q86VE0; -.
DR   SMR; Q86VE0; -.
DR   BioGRID; 130870; 52.
DR   IntAct; Q86VE0; 40.
DR   STRING; 9606.ENSP00000325402; -.
DR   iPTMnet; Q86VE0; -.
DR   PhosphoSitePlus; Q86VE0; -.
DR   BioMuta; MYPOP; -.
DR   DMDM; 74759426; -.
DR   EPD; Q86VE0; -.
DR   jPOST; Q86VE0; -.
DR   MassIVE; Q86VE0; -.
DR   MaxQB; Q86VE0; -.
DR   PaxDb; Q86VE0; -.
DR   PeptideAtlas; Q86VE0; -.
DR   PRIDE; Q86VE0; -.
DR   ProteomicsDB; 69990; -.
DR   Antibodypedia; 45635; 22 antibodies from 10 providers.
DR   DNASU; 339344; -.
DR   Ensembl; ENST00000322217.6; ENSP00000325402.4; ENSG00000176182.6.
DR   GeneID; 339344; -.
DR   KEGG; hsa:339344; -.
DR   MANE-Select; ENST00000322217.6; ENSP00000325402.4; NM_001012643.4; NP_001012661.1.
DR   UCSC; uc002pdt.4; human.
DR   CTD; 339344; -.
DR   DisGeNET; 339344; -.
DR   GeneCards; MYPOP; -.
DR   HGNC; HGNC:20178; MYPOP.
DR   HPA; ENSG00000176182; Low tissue specificity.
DR   MIM; 617861; gene.
DR   neXtProt; NX_Q86VE0; -.
DR   OpenTargets; ENSG00000176182; -.
DR   PharmGKB; PA164723403; -.
DR   VEuPathDB; HostDB:ENSG00000176182; -.
DR   eggNOG; ENOG502RV5V; Eukaryota.
DR   GeneTree; ENSGT00450000040421; -.
DR   HOGENOM; CLU_046143_2_0_1; -.
DR   InParanoid; Q86VE0; -.
DR   OMA; QEGGCPR; -.
DR   OrthoDB; 1378970at2759; -.
DR   PhylomeDB; Q86VE0; -.
DR   TreeFam; TF338618; -.
DR   PathwayCommons; Q86VE0; -.
DR   SignaLink; Q86VE0; -.
DR   BioGRID-ORCS; 339344; 12 hits in 1081 CRISPR screens.
DR   GenomeRNAi; 339344; -.
DR   Pharos; Q86VE0; Tdark.
DR   PRO; PR:Q86VE0; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q86VE0; protein.
DR   Bgee; ENSG00000176182; Expressed in oocyte and 113 other tissues.
DR   Genevisible; Q86VE0; HS.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; ISS:ARUK-UCL.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISS:ARUK-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISS:ARUK-UCL.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   InterPro; IPR028002; Myb_DNA-bind_5.
DR   InterPro; IPR001005; SANT/Myb.
DR   Pfam; PF13873; Myb_DNA-bind_5; 1.
DR   SMART; SM00717; SANT; 1.
DR   PROSITE; PS50090; MYB_LIKE; 1.
PE   1: Evidence at protein level;
KW   DNA-binding; Nucleus; Reference proteome; Repressor; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..399
FT                   /note="Myb-related transcription factor, partner of
FT                   profilin"
FT                   /id="PRO_0000344799"
FT   DOMAIN          12..84
FT                   /note="Myb-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00133"
FT   REGION          87..108
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          127..261
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          297..332
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          358..399
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           83..86
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250"
FT   MOTIF           382..385
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250"
FT   MOTIF           390..393
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        155..170
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        199..254
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        301..332
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        383..399
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   399 AA;  42508 MW;  F949A70588E0C454 CRC64;
     MASAAAGEAE ETTRLRKPRF SFEENQILIR EVRAHYPQLY GAQSRRVSVA ERRRVWDGIA
     AKINGITSWK RTGQEVQKRW NDFKRRTKEK LARVPHSTQG AGPAAEDAFS AEEETIFAIL
     GPGVAAPGAG AGAEEPPAAP SSQPPPPSAC PQRYVLSEDR REDRRADTSA HSKAGSSSPE
     PWARPSCTPQ EGGCPRPKER ESPPPSALQP VQLPRLALSP PPPAPPLPPP PPLAQVAPSP
     PSPPPPPRPP PTLSASDPSL DFLRAQQETA NAIRELAGTL RQGLAKLSEA LSALLPLLPG
     TPVDSLPPPL PPPPPPPPPP RPVLPPPAPK VEITPEPVSV VAAVVDGAVV AARGVIIAPR
     SEEGAPRPPP APLPPHDSPP HKRRKGFPTR KRRGRWKSP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024